October 09, 2018

"After Action Report" of our Congressional Briefing Day

Dear Kratom Warriors:

 

I wanted to take a few minutes and provide you with an "after action report" of our Congressional Briefing Day that was held on Capitol Hill earlier today. The AKA team joined other advocacy groups and subject matter experts in providing an in-depth briefing to Congressional and Senatorial staff.

The Briefing Day was an opportunity for us to share directly with key staff the truth about kratom. There was a buzz in the standing-room-only venues as we methodically debunked the misinformation being spread by FDA Commissioner Scott Gottlieb.

We want to thank everyone who participated and helped make it such a successful event.

You have our commitment that we will continue to pushback on the false information about kratom and that we will make sure your voices are heard.

See pictures from the Congressional Day Briefing

Sincerely,


Dave Herman
American Kratom Association

#FollowTheScience
#KeepKratomLegal
#TeamKratom
#KratomWarriors

September 25, 2018

SITSA UPDATE

Dear Kratom Warriors,

Our lobbyist just called, so I wanted to share with you the great news....because of your outreach over the last few days, the Senate has stood firm and decided that SITSA WILL NOT be added to the other opioid legislation.  

 

I have been truly humbled as I've seen the outpouring of action from the kratom community.  With thousands of emails and phone calls flooding Capitol Hill, you sent a loud message to lawmakers that they needed to oppose SITSA - and your voices were heard

 

Earlier this evening I spoke with a staff member on the Hill who commented that they were shocked how many people reached out to the Senate about kratom. 

 

His exact words, "the kratom folks sure know how to fight."

 

He's absolutely right. 

 

While this is a very positive development in the fight to protect kratom, we cannot lose focus that enemies of kratom still want it banned.  We must keep up the pressure and let lawmakers know we will not give up.  

 

From the whole team at the American Kratom Association, I want to personally thank you for your swift action in helping defeat the inclusion of SITSA....today has been a good day in the fight to protect kratom.

 

Sincerely,

Dave Herman

Chairman

American Kratom Association

#FollowTheScience

#KeepKratomLegal

#WeAreKratom

#TeamAKA

 

September 25, 2018

Copy Of -SITSA UPDATE

Dear Kratom Warriors,

Our lobbyist just called, so I wanted to share with you the great news....because of your outreach over the last few days, the Senate has stood firm and decided that SITSA WILL NOT be added to the other opioid legislation.  

 

I have been truly humbled as I've seen the outpouring of action from the kratom community.  With thousands of emails and phone calls flooding Capitol Hill, you sent a loud message to lawmakers that they needed to oppose SITSA - and your voices were heard

 

Earlier this evening I spoke with a staff member on the Hill who commented that they were shocked how many people reached out to the Senate about kratom. 

 

His exact words, "the kratom folks sure know how to fight."

 

He's absolutely right. 

 

While this is a very positive development in the fight to protect kratom, we cannot lose focus that enemies of kratom still want it banned.  We must keep up the pressure and let lawmakers know we will not give up.  

 

From the whole team at the American Kratom Association, I want to personally thank you for your swift action in helping defeat the inclusion of SITSA....today has been a good day in the fight to protect kratom.

 

Sincerely,

Dave Herman

Chairman

American Kratom Association

#FollowTheScience

#KeepKratomLegal

#WeAreKratom

#TeamAKA

 

September 24, 2018

FDA DEATH DATA ON KRATOM LINKED TO ADULTERATED PRODUCTS, NOT THE KRATOM PLANT ITSELF

American Kratom Association Demands a Recall on Scheduling Recommendation and Complete FDA Re-evaluation of Kratom Science.

 

WASHINGTON, DC – September 24, 2018 – The American Kratom Association (AKA) today called upon the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) to recall its recommendation to make the botanical a Schedule I drug after the National Institute on Drug Abuse (NIDA) confirmed that it is the illegal adulteration of kratom with other substances that is responsible for the deaths cited by the FDA in its recommendation.  Following confirmation from NIDA last week that it is the deliberate and illegal adulteration of kratom that has resulted in the deaths claimed by FDA, AKA requested that HHS Assistant Secretary of Health Brett Giroir, M.D., immediately recall the scheduling recommendation from the U.S. Drug Enforcement Administration (DEA) and direct the FDA to implement a complete reevaluation of the science on kratom.  

CLICK HERE TO READ LETTER FROM THE AKA

 

NIDA’s conclusion came after a two-month review of the scientific data on the safety of kratom and prompted the following statement:

Continue Reading

September 23, 2018

ATTN: VENDORS - AKA GMP Standards "Training Call"

Wednesday, Sept. 26 - 7:00pm ET

 

REGISTER FOR AKA GMP PROGRAM

 

Dear Kratom Vendors,

 

As a friendly reminder, we will be holding our next AKA GMP Standards Call on Wednesday, September 26 at 7:00pm ET.  The purpose of this call is to answer any questions, hear ideas from kratom vendors, and share next steps.  Your participation and input is critical to the success of this program.

If you still haven't had the chance to register for the program, please click here:

Please click here to complete the initial Registration Form.

 

It is critical that vendors within the kratom industry demonstrate a strong willingness to adopt and adhere to good manufacturing standards that will help produce safe kratom products.

 

Make no mistake, the FDA is going to use every advantage they can grab to distort the public image of kratom.  We must hold the industry to a high standard that looks to protect consumers. 

 

We are working on finalizing the details of the AKA GMP Standards Program and plan to launch on November 16 - giving vendors a couple of month to work towards compliance.  

Please complete the registration and email sherry@americationkratom.org with any questions.

September 21, 2018

CALL-TO-ACTION: OPPOSE SITSA

Dear Kratom Warriors,

We need your help today!

 

House Judiciary Committee Chairman Bob Goodlatte is demanding the U.S. Senate put SITSA back into the Senate Substitute H.R. 6, that passed on a vote of 99-1 in the U.S. Senate.  Chairman Goodlatte is reportedly holding final passage of the opioid bill hostage UNLESS the Senate is willing to add the provisions of the SITSA bill back into H.R. 6 as it was passed by the House. 

Continue reading

September 19, 2018

Kratom Industry GMPs Target Swaying FDA By Exceeding Agency Standards

Rose Sheet

Pharma Intelligence

NEWS

Author: Eileen Francis

Eileen.francis@informa.com

 

Executive Summary

“We want to show that the kratom industry is maturing, that people want to do the right thing,” says AKA Chairman Dave Herman. The standards go “well beyond” FDA's minimum GMP requirements for dietary supplements, AKA says.

The American Kratom Association expects a good manufacturing practices program it developed and a database of compliant firms will demonstrate the industry’s commitment to safety through self-regulation and help end FDA's objections to the herb's use in dietary supplements.

“We want to show that the kratom industry is maturing, that people want to do the right thing,” said AKA Chairman Dave Herman.

Read full article

September 13, 2018

The Kratom Truth Squad

CALLING ALL ACTIVISTS:

Join The Kratom Truth Squad

 

Dear Kratom Warriors,

 

As you know, the Food and Drug Administration (FDA) is working to have the Drug Enforcement Administration (DEA) include natural kratom on the list of Schedule I substances, thereby making its distribution and use illegal in the United States.

 

The American Kratom Association (AKA) is pushing back at every turn, demanding that the FDA, DEA, and National Institute on Drug Abuse (NIDA) follow the science, meet with the AKA and industry scientists in an open and transparent forum to discuss the safety and use of kratom, and to dedicate themselves to telling the truth on this issue.

Toward this end, we need your help 

Continue reading

September 12, 2018

LEGISLATIVE UPDATE September 12, 2018

Kratom Warriors,

Below is a link to the latest Legislative Update Report from Mac Haddow, the Senior Fellow on Policy at the American Kratom Association.  With your help and support, we are able to hire the necessary experts to fight

to keep kratom legal - Thank you!

 

Legislative Update: Sept. 12, 2018

 

 

Sincerely,
Pete Candland
Executive Director
American Kratom Association

#KeepKratomLegal

#FollowTheScience

#WeAreKratom

#TeamAKA

September 03, 2018

THE ATTACKS FROM THE FDA ARE ESCALATING TO BAN KRATOM

Kratom Warriors:

We're sounding the alarm.  If Scott Gottlieb continues to spew his lies about kratom, the DEA will schedule it.

 

A few days ago, we recognized the anniversary of the Notice of Scheduling for kratom.  Make no mistake, they tried to schedule kratom once and the FDA wants to do it again.

We need your help today to save kratom from being scheduledActually, we need your help right now.

CLICK HERE TO MAKE A DONATION TO HELP IN THE FIGHT.

Scott Gottlieb has declared war on kratom and he is filling Twitter, social media, and the mainstream media with one attack after another with one lie after another.

Gottlieb is saying kratom is a dangerously addictive opioid that kills people.

 

The scientists say that is not true – not even close.

Continue Reading

September 01, 2018

Two Years Ago

 

Kratom Warriors:

I just hung up from an interview with a journalist about the spate of rumors that had been circulating in Washington DC that the Drug Enforcement Administration (DEA) was likely going to announce a Notice of Scheduling for Kratom on August 31, 2018. While those rumors proved to be untrue, thankfully, these journalists focused on what the AKA expects will happen on the scheduling issue, and one reporter focused on a tweet posted by a former AKA official that he interpreted to be a self-serving attempt to claim credit for herself or the AKA for the success in 2016 in convincing the DEA to withdraw their Notice of Scheduling of Kratom.

 

The question itself gave me pause, because I have personally never thought in terms of one individual or one organization being in a position to legitimately claim that anything they did, or anything an organization did, being the reason for the DEA decision. In my mind, the power of 145,906 kratom supporters who signed the “We the People” White House petition to then President Barack Obama; the more than 6,000 kratom supporters who wrote to the DEA expressing their opposition to the proposed scheduling of kratom  when it was published on August 31, 2016 (despite the fact there was not even a formal comment period permitted under an Emergency Scheduling Notice); the more than 60 members of the U.S. Congress who wrote to the DEA and encouraged them to withdraw the Notice to Schedule Kratom; and the 23,232 comments (99% of which supported maintaining the legality of kratom) that convinced the DEA to reject the Emergency Scheduling proposal from the FDA. From that perspective, there simply is no room for any one individual to thump their chest and claim credit for what was only accomplished by the efforts of tens of thousands of kratom advocates.

Continue Reading

August 30, 2018

The Count Down Continues; #15DaysAndCounting

Kratom warriors,

Over the past year every communication made by the AKA to FDA Commissioner Gottlieb was routinely ignored.

When Dr. Gottlieb issued his Public Health Alert on kratom on November 14, 2017 and claimed 44 deaths were associated with kratom, we immediately challenged those conclusions and requested a meeting.

We were ignored.

AKA filed a formal complaint with the FDA showing repeated false claims about kratom made by the FDA were demonstrably false and failed to account for good science. We requested a hearing at the FDA on our complaint.

We were ignored.

When Commissioner Gottlieb announced on February 6, 2018 that the controversial PHASE computer modeling software proved kratom was an opioid, we asked for a meeting with kratom scientists to show the flaws in this claim.

We were ignored.

Since then, in every communication AKA has made with FDA we have reiterated our request for a meeting.

We were ignored.

When the FDA interfered with the posting of truthful and accurate information by NIDA about kratom overdose not being a cause of any reported death, it was a bridge too far for us.

Continue Reading

August 29, 2018

Naperville, Illinois Update

The AKA responded immediately on the proposed ban of Kratom in Naperville, Illinois, and we quickly reached out to the officials in Naperville and provided information.  However, a Board Member of the Kratom Trade Association (KTA) has informed the AKA that the KTA plans to take the lead in resolving this issue.  We encourage all to provide any grassroots advocacy support in their efforts to defeat this unfair ban.  The AKA remains committed to fighting these kinds of bans at every level, but in the spirit of cooperation and to focus resources on as many fronts as possible, we defer to the KTA for this fight in Naperville.

August 28, 2018

Register Now for the AKA GMP Standards Program!

First "Training Webinar" on Thursday, August 30, 7:00pm ET

Dear Kratom Vendors,

 

Registration is now open for the AKA GMP Standards Program.

 

Please click to complete the initial Registration Form:
 

As you all know, the FDA has been pushing for a ban on kratom for years and continues to rollout their misinformation campaign targeted at the public, legislators, and other government agencies.

 

Many of you live everyday under the constant threat of a kratom ban that will destroy or significantly damage your business and your ability to make a living.

Continue Reading

August 23, 2018

More than 40,000 Americans Petition DEA in Support of Kratom

WASHINGTON, D.C.—August 22, 2018—The American Kratom Association submitted an eleven-page letter and a petition signed by more than 40,000 Americans asking the U.S. Drug Enforcement Administration (DEA) to keep the current regulatory structure in place for kratom, a natural botanical in the coffee family native to Southeast Asia. 

CLICK HERE TO READ PETITION SIGNED BY OVER 40,000 AMERICANS WHO SUPPORT THE USE OF KRATOM

CLICK HERE TO READ PETITION TRANSMITTAL LETTER

Continue Reading

August 20, 2018

AMERICAN KRATOM ASSOCIATION ANNOUNCES MANUFACTURING STANDARDS TO PROTECT CONSUMERS FROM ADULTERATED KRATOM PRODUCTS

WASHINGTON, D.C., August 20, 2018 – The American Kratom Association (AKA) published its “Good Manufacturing Practice (GMP) Standards for the Manufacture of Kratom Products” to provide specific guidance to kratom manufacturers and vendors in the manufacturing and marketing of kratom products.

CLICK HERE FOR AKA GMP STANDARDS PROGRAM DETAILS

 

Dave Herman, Chairman of the AKA, affirmed the commitment of the AKA to establish a supply chain of safe kratom products. “The most important goal we have is to protect consumers,” Herman commented.  “We will maintain a public database of manufacturers and vendors who agree to comply with these standards so consumers can have a higher level of confidence that the products they purchase are from sources who are committed to safe kratom products.”

Continue Reading

August 16, 2018

Petition requesting that DEA Acting Administrator Uttam Dhillon immediately return the 8-Factor Analysis submitted by the FDA and reject their recommendation to schedule kratom as a Schedule 1 substance.

Dear Kratom Warriors,

 

The fight to keep kratom legal is getting more and more intense and once again, we need your help to send a loud message to the folks at the DEA and on Capitol Hill. 

 

Please click on the link within this email to sign the petition requesting that DEA Acting Administrator Uttam Dhillon immediately return the 8-Factor Analysis submitted by the FDA and reject their recommendation to schedule kratom as a Schedule 1 substance. With almost constant rumors and threats of an imminent Scheduling, it's critical that we all stand with one loud voice and declare that we won't back down.  

 

They need to stop the War on Kratom.

Read full update and sign the PETITION

August 15, 2018

Letter to Scott Gottlieb, M.D. FDA Commissioner and Nora D. Volkow, M.D. Director NIDA

Dear Commissioner Gottlieb and Director Volkow:
 
I write to formally request that the U.S. Food and Drug Administration (FDA) and the National Institute on Drug Abuse (NIDA) jointly host a meeting with leading scientists who have conducted research on the pharmacology and toxicology of kratom, surveys of kratom users, and addiction medicine specialists, many who have published peer-reviewed studies and presented at recent scientific meetings on kratom and its mitragynines.

READ THE LETTER

August 15, 2018

Kratom Association Calls FDA Review of Drug ‘Junk Science’ in Scathing Report

Kratom Warriors:

Everyone needs to read the Rolling Stone article to see the hubris and arrogance of the FDA in its demonization of kratom.

FDA Commissioner Gottleib, when confronted with the fact the previous death reports he claimed were attributable to kratom were WRONG, Gottleib has now dramatically revised the death numbers up, discounted the false reports he knows cannot survive the light of day, and when the Rolling Stone reporter asks for the data on the newly claimed deaths, THE FDA REFUSED TO RELEASE THE DOCUMENTS.

Even more astounding is the response to the question by the Rolling Stone reported on what scientific study Dr. Gottleib was relying on to support his claim that kratom “is an opioid and has the addictive features of opioid drugs” – for example, was there any documentation of opioid addicts who had begun as kratom as kratom users? The FDA answer: We do not have a list of specific examples.

The FDA spokesperson tried hard to bail FDA Commissioner out by claiming his statement is referring to “the traditional thinking of what addiction is and how it works. Kratom is an opioid and addiction to opioids is well-documented.”

The science on kratom proves that statement to be completely false. If anything, there are some kratom users who rely on kratom as an alternative pain management therapy, so they can stay away from or stop using opioids.

Dr. Jack Henningfield said it clearly in his 8-Factor Analysis that banning kratom will lead to more deaths because legitimate kratom users would be forced to the black market where adulterated kratom products spiked with dangerous substances abound.

We need sanity in this discussion. Send the Rolling Stone article to everyone to expose the latest FDA lies about kratom.

Keeping kratom legal,

Dave Herman

#FollowTheScience
#TeamAKA
#KeepKratomLegal

August 14, 2018

AMERICAN KRATOM ASSOCIATION ACCUSES FDA OF MANIPULATING, OBSCURING, AND IGNORING SCIENCE

FDA did not independently verify or perform due diligence on death reports cited in an effort to force

NIDA to list kratom as a Schedule 1 substance

 

 

WASHINGTON, DC – August 14, 2018 – Peer-reviewed documentation concerning 44 deaths that the Food and Drug Administration (FDA) has cited to persuade the Drug Enforcement Administration (DEA) to place natural kratom on the Federal Government’s Schedule 1 list of illegal substances disclose errors and omissions on the part of the FDA that the American Kratom Association (AKA) claims can only be seen as “deliberate.”

In a detailed white paper released today, AKA scientists and attorneys claim, “The FDA has also misled the DEA, the Centers for Disease Control (CDC), and the National Institute on Drug Abuse (NIDA) with incomplete, inaccurate, extrapolated, and distorted information on adverse events and deaths allegedly associated with the use of kratom to encourage unwarranted legislative and regulatory restrictions on kratom at the federal, state, and local government levels.”

Read full press release

August 06, 2018

WE HAVE THE PROOF OF FDA BIAS, NOW WE NEED YOUR HELP TO FIGHT BACK

Kratom Warriors:

The fight to protect kratom is clearly going to take all of us working together.  A few days ago, we sent out the email below highlighting recently obtained evidence that shows clear bias by some at the FDA against kratom.  I'm reaching out again because we need your help to push back on those who want to ban kratom. 

Continue Reading

July 30, 2018

The Facts on the NIDA “DrugFacts” website updates:

There are significant differences between the 2016 NIDA DrugFacts document posted on its

website, and it’s recent 2018 document:

See HERE

#TeamAKA #KratomChangesLives #IamKratom #KeepKratomLegal

July 30, 2018

SAFETY OF UNADULTERATED KRATOM AFFIRMED BY THE NATIONAL INSTITUTE OF DRUG ABUSE (NIDA)

WASHINGTON, DC – July 30, 2018 – In a recent update of its official position on the botanical kratom, the National Institute of Drug Abuse (NIDA) affirmed that, “Kratom by itself is not associated with fatal overdose,” explaining that only when the natural ingredient is contaminated or “laced with other compounds” has it been associated with deaths.

NIDA’s position clarifies and corrects an earlier statement by FDA Commissioner Scott Gottlieb that kratom has been associated with 44 deaths—sufficient, in his opinion, to justify placing the botanical on the Federal Drug Enforcement Agency’s (DEA) schedule that would prohibit kratom’s distribution and use, even in its pure form.

“NIDA’s position does not come as a surprise,” said Dave Herman, Chairman of the American Kratom Association (AKA), which is committed to protecting the rights of consumers who use kratom safely and successfully.  “The data used by the FDA to make its original claim are clear that the adverse reactions were caused by adulterated or contaminated kratom, polydrug use, or unrelated underlying health conditions of the decedent.  NIDA’s statement is consistent with these findings, and we call upon the two agencies to work together to remove the FDA’s scheduling recommendation for pure kratom and focus on protecting the rights of Americans who rely on it by removing adulterated and dangerous counterfeit products from the market.”

The FDA and NIDA have a long-standing formal agreement that both agencies must concur on scheduling recommendations submitted to the DEA.  “In extrapolating the data to a faulty conclusion—in an effort to place kratom on the DEA’s schedule—the FDA’s logic would require the prohibition of caffeine and even coffee because someone laced that drug with fen-phen or any other contaminant.  In fact, it could be applied to anything, even broccoli, once it has been contaminated with a dangerous substance.”  

NIDA’s position clarifies that natural kratom does not present a public health risk, and the FDA already has statutory authority to seize all dangerous adulterated and counterfeit products.  “The American Kratom Association joins the millions of consumers who safely use kratom, as well as the healthcare professionals and government leaders who support kratom in its pure form, in calling upon the FDA to follow the science, to allow consumer access to the natural botanical, and to use its efforts and energy to go after those who lace it illegally,” said Herman.  “We respectfully request that acting DEA Administrator Uttam Dhillon formally reject the FDA recommendation for the scheduling of kratom and return it to the FDA for immediate regulatory action against adulterated counterfeit kratom products.  This may require a little more effort on behalf of the FDA, but it is consistent with the science.  It is the right thing to do.  And it will put to an end the threat of criminalizing millions of Americans who rely on kratom for their health and well-being.”

 

The AKA announced its recommended standards for kratom manufacturers and vendors on July 18, 2018 to promote self-regulation in the kratom industry so that consumers could identify vendors who comply with FDA good manufacturing processes.  

 

ABOUT AKA

The American Kratom Association (AKA), a consumer-based non-profit organization, focuses on setting the record straight about kratom and gives a voice to those who are suffering by protecting their rights to possess and consume safe and natural kratom.  AKA represents tens of thousands of Americans, each of whom has a unique story to tell about the virtues of kratom and its positive effects on their lives. www.americankratom.org

MEDIA CONTACT 

Benjamin May, 202-413-0119 -- bmay@policyimpact.com

#KeepKratomLegal

#TeamAKA
#KratomChangesLives
#IAmKratom

July 25, 2018

LEGISLATIVE UPDATE MI 07-25-2018

REPORT ON MEETING WITH MICHIGAN STATE SENATOR RICK JONES

 

The good news first:  Senator Jones has agreed to file legislation that will protect consumer access to safe kratom products and specifically target bad actors who deliberately adulterate or contaminate kratom with dangerous substances to boost their effects and increase their sales.

 

When we first heard the report that Michigan State Senator Rick Jones had announced his intent to file a bill to ban kratom, AKA Chairman Dave Herman authorized me to immediately contact Senator Jones to see if he would be willing to meet to discuss this issue.  Senator Jones was very willing to meet, open to the discussion, and went the extra mile in arranging for the legislative team at the Prosecuting Attorneys Association of Michigan to join the meeting. The Prosecuting Attorneys Association had reported their concerns about alleged deaths in Michigan associated with kratom, and they hoped he would lead the effort to ban it.

Read full update

July 19, 2018

LEGISLATIVE UPDATE - Updated 07-19-2018

Updated 07-20-2018

The major focus of our legislative efforts this week on Capitol Hill has been to educate Members and staff on the difference between the natural leaf kratom, that science studies have proven to be safe for use by consumers, and the products that the FDA continues to cite as kratom that are actually products marketed as kratom that are adulterated or deliberately spiked with dangerous opioids and other substances.

This issue is critically important to our efforts to maintain the legality of kratom because the FDA has continued its campaign to demonize kratom despite the growing scientific evidence that their claims about deaths and adverse events “associated” with the use of kratom are wrong. The recently released Hemby study: https://onlinelibrary.wiley.com/doi/10.1111/adb.12639
published in Addiction Biology sent shock waves through the FDA corridors with the finding that mitragynine, the major alkaloid in kratom, “does not have an abuse potential and reduces morphine intake” which is exactly the pharmacologic activity for “candidate pharmacotherapies for opiate addiction and withdrawal.”

This study directly challenges the premise the FDA has advanced in its recommendation for the DEA to schedule kratom, namely that kratom has a high addiction profile and poses a risk to the public health.  FDA Commissioner Gottlieb has been critical of kratom on the now clearly discredited claim that kratom has “similar effects to narcotics like opioids, and carries similar risks of abuse, addiction, and in some cases, death.”1

Continue Reading

July 18, 2018

THE AMERICAN KRATOM ASSOCIATION (AKA) ANNOUNCES INDUSTRY GOOD MANUFACTURING PRACTICE (GMP) STANDARDS TO PROTECT KRATOM CONSUMERS

Las Vegas, Nevada - July 18, 2018 - With many of the largest kratom vendors in attendance at the Champs Trade Show in Las Vegas, the American Kratom Association (AKA) reaffirmed its commitment to providing consumers with safe kratom products, by announcing the AKA Good Manufacturing (GMP) Certification Program. 

 

Dave Herman, Chairman of the AKA, told the vendors at the Champs Trade Show that these strict baseline recommendations for GMP Standards for the manufacturing and distribution of kratom products are essential in protecting the safety of consumers, and will send the clear message to the FDA and federal and state legislators that we are committed to removing adulterated or contaminated kratom products from the marketplace, and we will not allow impermissible health claims to be made by any credible kratom vendor.”

Continue Reading

July 14, 2018

LEGISLATIVE UPDATE: JULY 14, 2018

Dear Members,



Attached are two reports that I wanted to share with you - both regarding the political landscape we are seeing on Capitol Hill.

 

I will continue to send out reports from our lobbying team that I think may interest you.

 

Midterm Legislative Forecast

 

Cook Political Report July 2018

 

Sincerely,

Pete Candland

Executive Director

American Kratom Association

July 09, 2018

LEGISLATIVE UPDATE July 9, 2018

The U.S. Congress returns today from its July 4th recess, and the U.S. Senate will begin its
process of “unbundling” the 57+ House bills on the opioid crisis that were consolidated
into H.R. 6 (“Patients and Communities Act”).

Politics played a key role in the decision by House Speaker Ryan to rush the package of
bills on the opioid crisis out of the House so the Republicans, who control the U.S.
House, can claim they have acted to combat the epidemic of deaths from the opioid crisis.

 

Politics will now flip that strategy on its head in the Senate where Republican Senate Majority Leader Mitch

 

McConnell will likely wait until November to consider any of these opioid bills – so that the roughly 12
vulnerable Democrats in hard-hit states like West Virginia will not be able to claim a “yes” vote on opioid
legislation.


This delay actually works in our favor because it provides more time to educate members of the Senate on
the truth about kratom, and that time will work in our favor.  READ Full Update

July 03, 2018

NEW KRATOM SCIENCE STUDY AT ODDS WITH FDA CLAIM THAT KRATOM IS A NARCOTIC-LIKE OPIOID

The American Kratom Association applauds the landmark science study published in the Addiction Biology journal that concluded that mitragynine “does not have abuse potential and reduces morphine intake, desired characteristics of candidate pharmacotherapies for opiate addiction and withdrawal . . .” that directly contradicts the FDA claims on kratom having the same effects of a classic opioid.

The study, co-authored by Christopher R. McCurdy, Scott E. Hemby, Scot McIntosh, Francisco Leon, and Stephen J. Cutler, isolated the potential high abuse of 7-hydroxymitragynine (7-HMG) when it is “adulterated or concentrated in commercially available kratom products, but noted that 7-HMG constitutes only 2 percent of the alkaloid content of kratom.”

Read more

June 23, 2018

CALL TO ACTION TO PROTECT KRATOM

Protect Access by American Consumers to Natural Botanical Plants and Herbs

The U.S. House of Representatives passed H.R. 6 on Friday that combined 58 different bills that attempt to end the scourge of the opioid epidemic in America.

 

The sponsors of H.R. 6 in the House admit it’s not perfect, and they are dead right on that point.

 

In the rush to show how serious the Congress is in addressing the opioid crisis prior to the mid-term elections, several of these 58 bills contain provisions that will actually deny Americans access to safe natural plants and herbs that help Americans manage their health and well-being.

Read full Call-to-Action HERE

June 21, 2018

AKA Works with Scientists to Author New Letter on Kratom

Nine Scientists Defend Kratom and Ask Senate and House Leaders to Keep Kratom Legal

 

Washington, D.C. - June 21, 2018 - Nine leading scientists delivered a letter to U.S. Senate and House Leadership condemning the FDA recommendation for scheduling of the natural plant as a Schedule I banned substance, and urging the DEA to return the recommendation to the FDA for further study and development of appropriate regulations to preserve consumer access for the 3 – 5 million kratom users in America.

 

The scientists directly challenged the claim of the FDA that kratom is dangerous, and concluded that none of the alleged deaths could clearly be tied to kratom overdoses. All of the data produced by the FDA shows the deaths were the result of the use of illegal drugs, polydrug use at improper doses with potential contra indications, or for completely unrelated circumstances, including a death of a person who died from a gunshot wound to the chest.

 

Read in full HERE

June 14, 2018

SITSA - Added note:

We understand that many people feel the need to call their House of Representatives member.  We do not feel that it would be of benefit, however, if you decide to call them before the House floor vote on Friday, feel free.

 

We will continue to focus our efforts on the Senate Judiciary Committee.  We are Not asking for calls to them yet. This could change at any time, when that does happen, we will issue a Formal Call-to-Action.

June 14, 2018

SITSA UPDATE

06-14-2018 11:30 am EST

 

The House Rules Committee voted on party lines, 6-4, to reject the Pocan/Gosar/Polis amendment that would have protected kratom from the SITSA scheduling authority given to the Attorney General.  This was not a vote on the merit of the amendment, but rather a procedural vote by the Republicans to reject ANY amendment that was not discussed or voted on by the Committee of jurisdiction.

 

The SITSA bill was originally assigned to two Committees: The House Judiciary Committee, and the House Energy & Commerce Committee.  When the SITSA bill was marked up by the House Judiciary Committee, the amendment to exempt kratom was not offered because of confusion by Chairman Goodlatte and his staff about the position of the kratom community on SITSA.  A newly formed group at the time had published a statement on their new website supporting SITSA, and the Judiciary Committee staff were directed to that statement by a member of that newly-formed advocacy organization, and they mistakenly believed that statement represented the views of the mainstream kratom community.

 

The House Energy & Commerce Committee intended to debate and accept amendments on SITSA in a Hearing, but that plan was short-circuited by direction by the House Leadership that all "opioid-related" bills would be voted on by Friday of this week, and there was no time to schedule a Hearing on SITSA, so the Committee waived jurisdiction and the SITSA bill was send to the House Rules Committee.

 

The important point for the Kratom Nation to understand is that the vote in the House Rules was not on the merits of the amendment but was actually a procedural maneuver to block a number of other amendments that had not been heard in the Judiciary Committee.

 

The SITSA bill, when passed by the House on Friday this week as anticipated, will go to the Senate Judiciary Committee where the kratom amendment will be presented and debated.  We will fight hard to have the amendment accepted.

June 11, 2018

URGENT SITSA UPDATE!!!!

Kratom Warriors:

The FDA has lobbied the Speaker of the House and they are trying to force the SITSA Bill to the House Floor without the amendment to protect kratom from a back-door scheduling maneuver.

The House of Representatives Rules Committee will hear this bill on Tuesday afternoon.

It is critical if you live in the Congressional District of one of these House of Representatives (who serve on the Rules Committee) CALL THEM IMMEDIATELY AND ASK THEM TO SUPORT THE POCAN AMENDMENT TO PROTECT KRATOM.

All Kratom Warriors should contact their own Congressman and tell them to support the Pocan Amendment.

Your help is urgently needed. Call immediately to protect kratom.

RULES COMMITTEE Members

 

Questions & Answers on SITSA

First, follow the link on the SITSA post. "Only" contact those that are on your list, in your district, on the rules committee. 

Second is what do I say? 
Simply say:  If you are calling the House Rules Committee and speaking to your Representative, simply tell him, " I am calling to ask you to support the Pocan Amendment to the SITSA Bill. He/she will know what you're talking about, in regards to SITSA. If they say they can't  support the amendment then ask him to Simply vote no on SITSA

Next, why is this important?
SITSA as drafted would significantly expand the universe of drugs or substances that DEA
could immediately control with little notice to legitimate stakeholders or input from experts
and with few curbs on the authority of DEA. In so doing, the proposed law would give DEA
the unfettered ability to eliminate access to such substances, despite what may be longstanding
and legitimate non-medical uses (e.g., industrial uses, uses in foods, uses in dietary
supplements) and would substantially curtail and burden legitimate scientific research and
product development. Furthermore, despite the reference to synthetic analogues in the title
of the legislation, the legislative language is so broad as to sweep in a range of drugs or
substances.  In essence, DEA (working with FDA) could schedule kratom on the claim that it is an opioid analogue (a claim publicly made by FDA Commissioner Gottlieb on Nov. 14, 2017).  SITSA does not require any justification from NIDA or HHS on the science, and the AG has complete discretion.

Add to that, if SITSA passes and the AG decides to ban Kratom using SITSA, we have no recourse for 5 years. Zero recourse...

Once it is scheduled "temporarily" under SITSA for 5 years, the AG can unilaterally continue it -- there is no judicial review permitted.  The only claim would have to be on Constitutional grounds, and that is a very expensive and lengthy process with a very uncertain outcome.

Those who make the claim that kratom could not be scheduled under SITSA have clearly not read the definitions that are so broad -- and combined with Gottlieb's claims -- puts kratom squarely in the sights of the regulators.

We don't have time to argue or speculate. The calls need to made ASAP.

 

Previous entry, SITSA Sequence of Events, should answer any additional questions you may have about this.

June 11, 2018

SITSA Sequence of Events

From Mac Haddow AKA Chief Lobbyist and Legislative Director

For everyone’s information, here is the sequence of events on SITSA:

1. SITSA bill is passed by the House Judiciary Committee last year after the National Kratom Coalition (NKC) – then a newly organized group of just a few weeks – lobbied the Committee in opposition to the AKA amendment to exclude kratom.

 

2. The bill was subject to a joint referral to the House Committee on Energy and Commerce, and AKA had commitments that when SITSA was heard AKA would have the opportunity to present its amendment. However, SITSA was never considered by E&C in either a hearing or a mark-up, even when about 17 other “opioid related” bills were marked up by the Committee.

 

3. Late last week, based on reports from staffers, the Speaker’s office directed that all opioid related bills – particularly those interdicting fentanyl at our borders – should be added to the package of House bills on the opioid crisis for a vote on the House Floor this week. SITSA was added because it does make the importation of opioid analogues illegal.

 

4. E&C waived jurisdiction on Thursday of last week, and SITSA will now be before the House Rules Committee. The rules required any amendments had to be filed by 3 PM on Monday.
a. Congressman Mark Pocan (D-WI) filed the kratom amendment, and Congressman Paul Gosar (R-AZ) has filed as a co-sponsor.
b. Our goal is to (1) lobby the Rules Committee to accept the Pocan/Gosar Amendment; and (2) convince as many other House members as we can to sign on as co-sponsors prior to the Rules Committee meeting tomorrow afternoon.

 

5. If the Rules Committee does not accept the Pocan/Gosar Amendment, it is possible it will be offered and considered on the House Floor – subject to the rule of the Chair for hearing amendments. Given this is as much a political play to highlight the effort by the House to fight the opioid crisis, there may not be a fair opportunity to offer the Amendment and have it fully debated.

 

6. If SITSA passes the House in its current form, we will take the fight to the Senate Judiciary Committee.

What is not true is that “any representative can add any amendment to any bill, at any time, whether it is needed or not.” Amendments can only be OFFERED when the rules permit, and those opportunities are limited.

More importantly, an amendment must survive (1) numerous procedural hurdles (including whether it is germane to the bill itself), and then (2) must have a majority vote. Many good amendments are discarded because they may be controversial, or they require too much time to debate to secure a majority vote. In the current environment where the opioid crisis is dominating many of the political races, there is a rush to judgment on to push every bill on these issues through the legislative process without careful consideration of the impacts.

Claims that AKA “started the panic about SITSA last year” is a grossly irresponsible claim. Expert legal and policy analysts could see the broad definitions that put kratom at risk of being scheduled under SITSA, and Commissioner Gottlieb proved we were right with his claims "kratom is an analogue of an opioid". That is all the Attorney General would need under SITSA, given there is no requirement for science to drive any scheduling decision.

The kratom community should be unified in its goal to protect kratom. Even if there are some who do not think Kratom could or would be subject to SITSA, we should adopt the “better safe than sorry” strategy and fight for the Pocan/Gosar amendment. Then we can say with ABSOLUTE CERTAINTY that SITSA cannot be used to schedule kratom.

June 07, 2018

AKA Fundraising Policy

The American Kratom Association (AKA) welcomes the support of every kratom advocate. There is a secure contribution portal on our website that allows for individuals and businesses to make contributions where we can provide optimum security for confidential information of donors.


Some supporters have offered to do fundraising in their communities for the benefit of the AKA, and we deeply appreciate these expressions of support. However, in order to protect the integrity of our tax-exempt status as a 501(c)(4) entity, and to assure that donations by supporters are credited to the authorized bank account of AKA, it is essential that we document and account for each individual contribution.


Accordingly, any individual or entity that wishes to conduct a fundraising event in your community for the benefit of the AKA must submit a request for authorization prior to advertising or commencing any such fundraising effort. Requests should be submitted to pete.candland@americankratom.org.


We have received some complaints from individuals who have made donations that they believed were for the benefit of the AKA only to find out that the money had been diverted, or only a portion of the money intended to support AKA’s advocacy efforts, was presented for deposit to our authorized bank account. We hope all understand the importance of receiving prior authorization for any fundraising effort undertaken on behalf of the AKA.


We advise everyone to verify an AKA authorization for a local fundraiser by checking our website at www.americankratom.org for a list of fundraising activities approved by the AKA.


The AKA deeply appreciates the support of the Kratom Nation that has allowed us to effectively advocate to keep kratom legal, and we will continue these efforts with your continued support.

June 04, 2018

Fundraising Goal Achieved

Dear Kratom Warrior:

 

Over the last several days, I have been truly humbled by the outpouring of support and generosity by the defenders of kratom. 

 

Last week, we asked you to help us achieve our goal of raising $28,450 that would allow us to pay for a scientific push against the misinformation campaign the FDA is pushing about kratom. The opportunity to pay for this much needed work was even more exciting due to the generosity of one of our donors who agreed to match each donation $1 for $1. 

 

Well, you all stepped up and helped raise over $70,000! 

 

From the bottom of my heart - THANK YOU! 

As promised, your $70,000 now becomes $140,000!

 

This money will now allow us to move forward in hiring several teams that will descend on states like Wisconsin and Rhode Island, and in local communities like Jerseyville, IL where we need to make the case for repealing bans on kratom that currently exist. Your tremendous response and support will also allow us to commission Dr. Jack Henningfield to develop a set of industry standards that will further protect consumers and make the industry safer for everyone. 

 

Make no mistake...your generosity sent a clear message to the FDA that we will not sit idly by why they spread lies about kratom. 

 

The truth is on our side - kratom is safe, not highly addictive, and helps millions of people live a happier life. 

 

I also want to address an important question raised by some donors, and a few who declined to donate despite supporting the cause, regarding how donor lists are handled by the AKA.

 

AKA does not sell our donor lists to anyone. 

 

The AKA also withholds names of individual donors that are protected by IRS filing regulations so no other organization can take those donor names and solicit contributions from you. We fully respect your privacy, and we know how irritating it is to be barraged by groups who have purchased donor lists from other organizations and charities, and that is why you have our commitment to not sell your name and contact information to anyone.

 

You have my word on that, and I will not violate that trust.

 

You have our commitment that we will continue to fight to protect kratom. I know that with all of us working together, nothing can stop us. 

 

Thank you!

 

Dave Herman, Chairman

American Kratom Association



If you would like to donate, please click HERE

May 30, 2018

FDA Commissioner Gottlieb Won't Stop the Attack on Kratom

We need your help to fight back!

 

MATCH MY GIFT TO HELP THE AKA FIGHT BACK AGAINST THE FDA ATTACKS

 

Dear Kratom Warrior:

FDA Commissioner Scott Gottlieb smells blood in the water, and he is doubling down on trying to force the DEA to ban kratom by making it a Schedule I drug like heroin and fentanyl.

And Gottlieb has turned the FDA propaganda machine into high gear by filling the airways and headlines in the media with his lies about kratom, so we can't afford to lose another minute in fighting back.

If you’re like me, I am tired of the lies and the political shenanigans that the FDA is pulling. I am sick of the false reports the FDA is flooding the media with about kratom.

We are excited to announce that a generous donor has offered to match every donation AKA receives this week!

That means your donation will have DOUBLE THE IMPACT! If you have donated in the past to the AKA, thank you. This is an all-out war and we are far from finished. We need continued and ongoing support from the kratom community to keep kratom legal. With all donations matched, you have the chance to double the impact of your gift and help us fight the FDA harder than we have before.

 

I am ready to authorize our scientific and PR teams to debunk the FDA lie that kratom is a dangerous opioid and that kratom kills people. But I am $28,450 short of our goal to tell our side of the story. 

 

The AKA is counting on grassroots supporters like you to fight back against the FDA’s insane war on kratom – but I have to make the commitment to authorize the campaign to publicize our scientific data by midnight tonight or the price increases and we lose our window of opportunity.

 

If we miss this goal, we could lose our best chance to convince the DEA the FDA is flat out lying. We need to tell the DEA that the deaths the FDA is claiming to be “associated” with kratom use are WRONG! And we have the science to prove it.

 

Will you rush $100 or more immediately to protect kratom and tell the DEA to make the FDA prove its false claims about kratom?

 

DONATE $50 (BECOMES $100)

DONATE $100 (BECOMES $200)

DONATE $200 (BECOMES $400)

DONATE $500 (BECOMES $1,000)

OTHER AMOUNT CLICK HERE

There really shouldn’t be a question about the safety of kratom. Kratom has been used safely for centuries in Southeast Asia, and for decades here in the United States.

 

But the sad truth is, this is an uphill battle against the FDA. They used their bogus science and lies to convince the Assistant Secretary of Health at HHS to forward the scheduling of kratom recommendation to the DEA.

 

And our fight will not end when we convince the DEA to send the kratom scheduling recommendation back to the FDA just like they did in 2016.

 

The FDA is telling law enforcement officials and state pharmacy boards across America that kratom is deadly – and they have to ban it in their states and local communities.

 

This is a fight on all fronts. Can we count on you?

Thanks for coming through. It means the world for all of us!

Dave Herman, Chairman

American Kratom Association



YES, DAVE!  I WILL DONATE TODAY & MATCH MY GIFT!

On Social Media: please use

#IAMKRATOM #KEEPKRATOMLEGAL #TEAMAKA #KRATOMCHANGESLIVES

May 25, 2018

Legislative sessions continue to wrap-up

As legislative sessions continue to wrap-up across the country, we wanted to provide a brief update on our efforts in the following states where we have either paid lobbyists or working with other lobbying teams. 

 

Kansas - kratom was removed from SB 282 and signed by governor

Illinois - working with our lobbying team to monitor

Louisiana - HR177 passed on 5/18 to request the LA Dept. of Health to study the scheduling of kratom

Minnesota - SF 2578 passed with an under 18 ban - waiting for governor's signature

Mississippi - kratom was removed from SB2892 and signed by governor

New Jersey - monitoring A2865 (carryover from A3281) which criminalizes kratom.  Pending in the Law & Public Safety Committee

New York - continue to monitor multiple bills 

Tennessee - SB2258/HB1832 passed with an under 21 ban on kratom 

West Virginia - kratom was removed from HB 273 and signed by governor

#TeamKratom

#KratomChangesLives

#WeAreKratom

May 23, 2018

The FDA and Their Crusade to Ban Kratom

Kratom Warriors:

 

We are under direct and constant assault by the FDA and their crusade to ban kratom.

 

The agency literally has unlimited money and an army of public relations experts who are flooding the media with their anti-kratom propaganda every day.

 

They get away with deliberate lies about kratom safety and use false reports of alleged deaths and adverse events about contaminated and adulterated kratom products to mislead Congress, state legislatures, the media, and the public into thinking all kratom is unsafe.

 

All of this to cover up the plain fact that the FDA has failed in its mission to protect the public from unsafe adulterated and contaminated products – which is the number one consumer safety duty they have under laws passed by Congress. 

 

The FDA uses these lies as their justification for an unfair import alert to choke the supply of safe kratom plants into the United States, and their clear agenda is to ban the sale of all kratom in the United States.

 

FDA Commissioner Gottlieb is leading this war on kratom with a constant stream of bogus and irresponsible claims that kratom is an opioid analogue, and that it is just as addictive and deadly as opioids themselves.

 

These lies are part of a broader FDA agenda to strip Americans of the freedom to make their own informed choices about products they use to maintain their health and well-being.  Well-informed consumers do not need a Washington bureaucrat dictating what we can and cannot do in making choices between safe natural herbal products and chemically formulated products the FDA regulates.

 

And isn’t that the heart of the problem?

 

The FDA wants to dramatically expand its regulatory reach into our lives, increase its army of regulators and bureaucrats, and strip us of our ability to make our own informed decisions and choices on the products we use.

 

We know kratom is safe. 

 

We have expended blood and treasure to scientifically study kratom, and we have the evidence that conclusively proves that kratom is safe.  We have completely debunked false claims of deaths, addiction, abuse and harm.  When given the chance to present the facts to policy makers, armed with the compelling science and research that proves the safety of kratom, we have been successful in multiple jurisdictions in stopping potential bans.

 

Our success is more remarkable given that we have to fight the vast and robust propaganda machine of the FDA and the DEA who flood the information channels to state law enforcement and state pharmacy boards with their lies about kratom. When members of Congress and state legislators see the evidence that proves we are telling the truth about kratom, more and more are willing to join us in resisting the lies and propaganda of the FDA. 

 

I was asked by a reporter the other day who is the biggest enemy of the kratom community, and my answer may surprise you.

 

It really is not the FDA or the DEA.

 

We can, when given the opportunity, show the evidence on the safety of kratom.

 

Our biggest enemy are irresponsible vendors who fail to maintain the safety and integrity of the supply chain in delivering quality kratom products to consumers.

 

Vendors who fail to manufacture and package kratom using accepted standards to ensure product purity are our biggest enemy.

 

Vendors who deliberately adulterate pure kratom with other dangerous or unapproved substances are our biggest enemy.

 

Vendors who make impermissible health claims to mislead consumers into buying their products are our biggest enemy.

 

Vendors who sell kratom spiked with dangerous illegal substances at potentially toxic doses – like what happened in Sweden in 2009 where 9 people died from a toxic mixture of kratom powder with a deadly concentration of O-desmethyltramadol – are our biggest enemy.

 

The FDA jumps on every misbranded, mislabeled, adulterated, contaminated, and poorly packaged kratom product and claims that those products are just kratom. And that is why kratom has to be banned.

 

It outrages me when I read reports of a few irresponsible kratom vendors who make false and unsubstantiated health claims about kratom, or those kratom vendors who are just irresponsible in the way they manufacture, package and ship their products to unsuspecting kratom consumers.

 

Those enemies hand the FDA their daily headlines to smear legitimate kratom vendors, and they hand the FDA the weapons to demonize kratom as an unsafe plant.

 

Those irresponsible vendors are our biggest enemy, and I am committed to putting them out of business once and for all.

 

WHO ARE WE?

 

We are a community that believes that Americans have the right to choose the products we want to use for our health and well-being when used responsibly.

 

WHO ARE WE?

 

We are a community that recently came together at a Kratom Leadership Summit to unite in an effort to commit to protect consumers, develop a set of standards to demonstrate our commitment to self-regulate the kratom industry, and to unite in building increased confidence of consumers in the quality and safety of kratom, all for the common good of the kratom community.

 

WHO ARE WE ?

 

We are average Americans -- mothers, fathers, sisters and brothers in the mainstream of American society -- who oppose government overreach into our private lives.  We are Americans who support responsible regulation by an FDA that fulfills its true mandate to ensure products are manufactured and packaged safely to protect against adulteration and contamination by rogue vendors.

 

When I was asked to become the Chairman of the American Kratom Association, I told our Board that my most important priority would be to ensure the safety of responsibly manufactured and packaged kratom products so the kratom consumers could have full confidence they could safely use kratom products.

 

It is a core part of the AKA mission:  AKA strongly condemns the improper and impermissible medical claims made by some unethical and irresponsible vendors.

 

The AKA fully supports the FDA and their legitimate efforts to protect consumers from impure, adulterated, and contaminated kratom products marketed by bad actors.

 

The AKA believes we must self-regulate the kratom industry for the benefit of all consumers and vendors. 

 

The AKA is fully committed to supporting a growing kratom industry that protects consumers, delivers kratom products with acceptable purity, quality, and safety.

 

When we do this, the FDA will have no weapons to fight us.  The FDA will be left with a discredited propaganda campaign that policy makers will see for what it is:  a brazen and naked attempt to increase its regulatory control of every American.

 

That is why we must do everything in our power to protect the kratom community, and I pledge my full efforts to doing just that.

 

Dave Herman

Chairman

American Kratom Association

 

#TeamKratom

#KratomChangesLives

#WeAreKratom

May 23, 2018

Tennessee Update

News to share from Tennessee from the BEA

BEA

Tennessee - The conference committee of 3 house members and 3 senate members met this morning. They were able to reach a compromise. The conference committee report was drafted, signed by all committee members, and filed in both the House and Senate. The House voted on the conference committee report. It passed the house just a few minutes ago by a vote of 86-2.

Conference Committee Report on House Bill No. 1832 / Senate Bill No. 2258
The House and Senate Conference Committee appointed pursuant to motions to resolve the differences between the two houses on House Bill No. 1832 (Senate Bill No. 2258) has met and recommends that all amendments be deleted.
The Committee further recommends that the following amendment be adopted: by deleting Sections 10 and 11, substituting instead the following, and redesignating the subsequent sections accordingly:
SECTION 10. Tennessee Code Annotated, Section 39-17-452(a), is amended by adding the following as a new subdivision (a)(3):
(A) It is an offense for a person to knowingly:
(i) Sell, or offer for sale, Kratom unless labeled and in its natural form; (ii) Distribute, sell, or offer for sale, Kratom to a person under the age of
twenty-one (21) years; or
(iii) Purchase or possess Kratom if under the age of twenty-one (21)
years.
(B) For purposes of this subdivision (a)(3):
(i) "Labeled" means a label containing the manufacturer's information and a warning that includes, at a minimum, "Warning: Do not use if you are pregnant or nursing. It is illegal to possess Kratom if under 21 years of age. Consult your healthcare professional before using. Do not combine with alcohol or medication. Consult a doctor prior to usage if you have any heart disease, liver disorder, high blood pressure, or medical condition or take medication."; and
(ii) "Natural form" means dried, cut, and sifted Kratom leaf or raw Kratom leaf powder.

Again, We are waiting on signature from the Governor and Session end.

We would like to thank Our Lobbyists and the Teamwork that brought us to this point.

#TeamKratom
#KratomChangesLives
#WeAreKratom

April 12, 2018

VENDOR SUMMIT

Invitation to Leadership Summit for Kratom Vendors on April 30th in Atlanta

Please email robin.graham@americankratom.org if you want to attend. Seating is limited.

 Key stakeholders in the kratom industry will discuss the salmonella outbreak, industry standards, and the fight to protect kratom. Featuring Dr. Jack Henningfield, Dr. Jane Babin and Mac Haddow.

Please feel free to share this with your vendors.....

April 06, 2018

TO ALL KRATOM VENDORS

FROM THE DESK OF DAVE HERMAN

CHAIRMAN

AMERICAN KRATOM ASSOCIATION

SALMONELLA:  FACT AND FICTION

 

The Salmonella outbreak in some kratom products has dominated the news cycle across the country over the past three weeks, largely because of the war on kratom that the FDA is waging in their broader effort to criminalize kratom manufacturers and consumers.  That War on Kratom is the fiction of the day, and the FDA should end its campaign of misinformation.

Salmonella contamination is a serious issue, and it must be dealt with appropriately to eliminate both the current source, and to prevent re-contamination by implementing appropriate sanitizing procedures on all equipment that may have been used in the production of kratom products.  This is a critical step because Salmonella bacteria can cross-contaminate products if production equipment is not properly cleaned.

 

Heat and chemical processing are the enemies of Salmonella bacteria, and they should be effectively used to make your processing facilities Salmonella-free – as opposed to just getting a test result of “Salmonella negative.”  These procedures must be implemented to contain and ultimately end the Salmonella outbreak that has been traced to the supply chain of some kratom raw materials.

 

The AKA’s first concern is the safety of kratom consumers.  I am encouraged that responsible kratom suppliers that we have spoken with share this concern.  Product safety for consumers and the protection of their businesses are the overwhelming messages of concern that we have received.

 

ACTING RESPONSIBLY; BEING TRANSPARENT; AND TELLING THE KRATOM STORY.

 

The good news about any Salmonella outbreak is that there is an endpoint once the source of the bacteria is identified, and that is true for any kratom contamination that may currently exist. The Centers for Disease Control (CDC) is currently managing Salmonella outbreaks in dried coconut, chicken salad, raw sprouts, and frozen shredded coconut (Vietnamese). 

 

It is clear that the FDA is exploiting the current Salmonella outbreak in kratom to advance their broader battle to ban kratom in the United States. No one is hearing that all consumers should stop consuming dried coconut, chicken salad, raw sprouts, or frozen shredded coconut. Yet, that is the central message the FDA is promoting through its public relations machine on kratom.

 

However unfair that messaging is on kratom, it is critical that every kratom product that is identified with a potential Salmonella contamination carefully follow the requirements of the FDA and CDC to document that appropriate steps have been taken to eliminate the public health threat.

 

The AKA strongly recommends that all of your interactions with these government agencies be respectful, responsive, and conducted in a way to develop a relationship of trust as quickly as possible.

 

The bad news is that the FDA is aggressively using new authority granted under the Food Safety Modernization Act that grants the FDA the authority to order a recall of food products when it determines "that there is a reasonable probability that the food product is adulterated under section 402 or misbranded under section 403(w) and use of or exposure to such article will cause serious adverse health consequences or death to humans or animals."

 

The triggering event for the utilization of this authority requires that the FDA has made an affirmative determination that a product that you are manufacturing and/or distributing has been contaminated with Salmonella. You are within your rights to request testing documents utilized by the FDA or CDC in making this determination.

 

Because there are also potential product liability issues, you be well advised to consult an attorney on these issues.

 

You should provide the attorney with critical information regarding kratom and demonstrate your willingness to do what is necessary to secure the supply chain to consumers to assure your product is Salmonella free.

 

You can also visit the AKA website to obtain the latest information and science on kratom.  On the AKA website ( https://www.americankratom.org/ ), there is a button on the front page labeled “Media.”  The first item on the pull-down menu is “Kratom A-Z.” Key information items are listed in this section with a short explanation for each item.  This information will be useful as you responsibly deal with either the FDA or CDC in addressing a potential Salmonella contamination of your product line.

 

·         Your product must be tested for safety.  The proof of this lab testing has to be current and specific regarding the purity of any product being sold to the public.  This testing should be done by more than one lab as a safety cross-check on the accuracy of the tests.

·         Document each communication with the government officials you deal with on this issue and ask for written copies of any information that reference as the basis for their inquiries or actions.

·         Respond to all demands made as quickly as you can, following the advice of your attorney, to avoid allowing the government to take more aggressive actions against you and your kratom products.

 

You also have rights just like any other citizen, and if you believe you have been treated unfairly, you can inform you congressional delegation about any missteps by either the FDA or CDC.

 

·         Make appointments and meet with your local legislators and your Federal representatives for both the House of Representatives and the US Senate.

·         If there are other Kratom merchants in your area, meet with them to form a local council that becomes a group that can be considered Key Opinion Leaders (KOL).

·         These meetings are your path to explain your fears regarding the safety of the consumer and your businesses.  Bring handouts.  Show that your key efforts are all based on cooperation and you want to be able to come back to these people if a problem arises.

·         As new information becomes available, share that with those legislators and staffers that you have met with on Kratom.

·         Contact your local media and arrange to meet with them and share the information you have gathered.  Local TV, newspapers and radio stations are your target audience.

·         Join a business group in your area like the local Chamber of Commerce and introduce your business to this community.  The more people know about your business, the more local support you will receive.

 

In the broader picture, be sure you are a registered voter. Be sure everyone that represents you or is a member of the above group is a registered voter.  We have a right to stand up for ourselves, and the right to hold the government accountable for their actions.

 

Sadly, I have heard that there are some vendors who think that "laying low and staying under the radar" is the best way to protect their business operations. While that may work for a while, it will not serve either your business interest or kratom consumers over the long term.

 

We believe the FDA and CDC have a duty to protect American consumers from unsafe food products, and we support responsible regulatory actions to assure consumers are protected.  We also believe that these agencies must not use the Salmonella outbreak as a pretext to pursue their own biased agenda to ban kratom from the marketplace. We must keep them accountable for their actions

 

The AKA can help in such cases if you provide us with information and data on any unfair or unreasonable treatment you receive from the FDA or CDC in your efforts to comply with requests from them to address any documented Salmonella contamination in your product line.

April 03, 2018

Kansas Update on SB282

The Conference Committee in Kansas agreed to accept the Amended House Version of SB282 which removed Kratom. We will continue to monitor this to make sure nothing changes.

Please, please take the time to reach out and say Thank You to all the Legislators that listened to the emails and phone calls. Once again, we have shown our voices can and will be heard.

#KratomChangesLives
#WeAreKratom
#TeamAKA

March 22, 2018

Good News Minnesota!

Good News Minnesota! Due to the Diligence and hard work of all of you, as well as our Minnesota Lobbyist and Mac Haddow, we have both House and Senate bills amended to over 18.

We need each of you to reach out to the Senators and Representatives and say a big Thank You to them for listening to you.

We will also need to continue to monitor the bills to make sure that no one tries to put kratom back in. This is not officially over until the session ends no later than May 21st.

Please give a HUGE thank you as well to Joanna Hosek Gurley, Jenn 'Sherman' Langford and Annette Peters. They did an amazing job with their testimonies in the House and Senate. They showed that kratom is for everyone and that the average kratom consumer is no different than they are.

#TeamAKA
#WeAreKratom
#KratomChangesLives

March 16, 2018

ADVISORY: Kratom Consumer Caution

The American Kratom Association (AKA) strongly urges all kratom consumers to carefully select the vendors from whom they purchase kratom.

 

When selecting vendors to purchase kratom, reward responsible vendors who:

 

● Protect the supply chain for the kratom plants;

● Adhere to good manufacturing practices;

● Follow all Food & Drug Administration (FDA) regulations in the claims made for their kratom products; and

● Responsibly act when situations arise with their products that create potential safety concerns.

 

Vendors who make illegal health claims on their kratom products, including therapeutic claims that make the kratom product an unapproved drug, should be avoided. These vendors actually increase the threat of the government scheduling kratom because of their irresponsible actions.

 

The AKA supports appropriate enforcement actions by the FDA against kratom products that are adulterated or contaminated, or that make health claims in violation of the Food Drug and Cosmetic Act or the Dietary Supplement Health Education Act.

 

Kratom products that substantially alter the concentration of the kratom alkaloids to enhance the effects of kratom should be subject to review by the FDA as a new dietary ingredient.

 

The AKA has learned that some kratom leaves that are being marketed have been sprayed with "spiked mitragynine or 7-OH chemicals" to enhance the effects of the natural kratom botanical. This constitutes an illegal adulteration of the kratom plant. Those products, and any vendors involved in this illegal conduct, should be avoided at all costs.

Help Support the Fight to Protect Kratom

March 13, 2018

The War on Kratom being waged by the Food and Drug Administration (FDA) requires the kratom community carefully allocate our resources to deliver the most powerful message possible to public policy decision-makers in the U.S. Congress and the Trump Administration.

 

This War includes the FDA’s public acknowledgement that a scheduling recommendation has been transmitted to the DEA that would criminalize kratom users – everyday people like you.

 

Significant resources are also being required to fight this War in a number of states that are considering bans on consumer access to kratom.

 

The AKA and the BEA are united in our belief that the kratom community is best served right now by focusing our resources on educating policymakers on the science that clearly demonstrates kratom is safe.  The time for grass-roots advocacy will come when, and if, a scheduling recommendation is made by the DEA, as it did in September 2016.

READ FULL STATEMENT

March 08, 2018

The AKA and BEA will be working together for the common goal of saving kratom

"You can do what I cannot do. I can do what you cannot do. Together we can do great things" - Mother Theresa

Over the years, many questions have been positioned to us as to why this hasn't been done. While there may have been differences in the past on which paths to take, at the end of the day in our hearts we know the destination is the same for each of our organizations. We all want kratom to be legal for the community and in doing so for people to have the right to live better lives. No more, no less.

The AKA and BEA will be working together for the common goal of saving kratom in America.

This week there are two critical state actions on kratom that require the attention of the kratom community, in Kansas and Tennessee. The American Kratom Association (AKA) and the Botanical Education Alliance (BEA) both agreed to collaborate in each respective state. Resources and lobbying efforts in will be provided by the AKA for Kansas and by the BEA for TN. We believe this allows us to more efficiently allocate our resources and achieve our goals to protect consumer access to kratom.

 

The Kansas House Health and Human Services Committee will hold a Hearing today at 1 PM to address SB 282, a bill that will add kratom to the Kansas controlled substances list. On Monday, the Committee held an informational Hearing where the AKA was represented by Mac Haddow, our chief lobbyist, and following which Committee Chairman Daniel Hawkins committed to proposing an amendment to strip kratom from the proposed legislation.

 

In Tennessee, after a strong testimony from BEA board members Travis Lowin, Angela Watson, and 3 members of the kratom community, the Health Committee voted 6-3 to remove kratom from bill HB #1832. There is another hearing next week where the BEA will be attending to testify again in order to ensure the language does not get added back in the bill.

 

The AKA and BEA are committed to working together in these two states, and others, as we continue our fight for the right of consumers to make their own decisions on their health and well-being.

February 18, 2018

#IAmKratom Day/Week Outline - TUESDAY, FEBRUARY 20, 2018

AMERICAN KRATOM ASSOCIATION is Proud to Sponsor:

#IAmKratom Day/Week Outline - PLEASE SHOW YOUR SUPPORT ACROSS SOCIAL MEDIA

TUESDAY, FEBRUARY 20, 2018

 

This Document May Be Shared At:
https://tinyurl.com/IAmKratomDay

GET THE PICTURES HERE:

#IAmKratom Day Photos & Facebook Banners - Approved for Public Use EVERYWHERE
https://tinyurl.com/IAmKratomDayPhotos

#IAmKratom Day Facebook Frames:
https://tinyurl.com/IAmKratomMantra (black text at top)
https://tinyurl.com/IAmKratomMantra2 (white text at top)

 

Please, feel free to use our photos, banners and suggested posts. Please, remember to use the hashtag,

 

#IAmKratom with your posts!

 

Reason: February 20 is an awareness launch day for the Kratom community. This is a day for the entire kratom community to show friends/family, the FDA and the world, that the Kratom community is a wonderful group made up of normal people. Many people, myself included, have had trouble telling their friends/family about Kratom because they fear stigmatism. There has, unfortunately, been more bad press than good press about kratom. This is a way for us to all stick together and let the world know that we feel good about our healthy choice, we love kratom and we are willing to defend our rights. #IAmKratom

 

Mantra:  #IAmKratom
I Am a Friend. I Am a Family Member. I Am a Citizen. I Am a Taxpayer. I Am Somebody You Know. I am Healthy. I am Happy. I am Kratom.

 

Suggested Posts - Feel free to cut/paste and add your own spin!

 

Please, copy, post and share even if you do not personally use kratom. This is for the entire pro-kratom community to band together. Together #WeAreKratom

 

#IAmKratom I Am a Friend. I Am a Family Member. I Am a Citizen. I Am a Taxpayer. I Am Somebody You Know. I am Healthy. I am Happy. I am Kratom.

 

#IAmKratom - A good friend or family member of mine benefits from Kratom

 

#IAmKratom - I support the citizens’ right to make their own health/wellness choices

 

#IAmKratom - I choose natural remedies over chemical compounds

 

#IAmKratom - Kratom provides me with calm focus and enhances my work

 

#IAmKratom - Kratom has changed my life for the better

 

#IAmKratom - Kratom inspires me to live a healthy lifestyle

 

#IAmKratom - Kratom is an integral part of my fitness and wellness lifestyle

 

#IAmKratom - Kratom helped me defeat a dangerous addiction

 

#IAmKratom - Kratom is a cousin of the coffee plant, with similar characteristics

#IAmKratom - Kratom saves lives

#IAmKratom - I am humbled by nature’s gifts

Or, whatever you think best describes your personal kratom experience. Thank y’all so much! Please, remember the hashtag, #IAmKratom

 

Please, consider a donation to the American Kratom Association:

www.americankratom.org

February 12, 2018

STOP THE CRIMINALIZATION OF AMERICANS WHO SAFELY USE KRATOM

SIGN THE PETITION

President Donald J. Trump
Kellyanne Conway, Assistant to the President on the Opioid Crisis

We the undersigned ask for your immediate action to protect the freedom of consumers to make their own health care decisions, and stop the Food and Drug Administration (FDA) from their broad regulatory overreach and the criminalization of millions of Americans who use kratom. 

Kratom is a safe herbal supplement that is used by Americans to manage their health and well-being.  Many have found kratom to be an effective alternative pain management therapy to dangerously addictive and deadly opioids.  Leading scientists have concluded that banning kratom will create an unsafe kratom black market, and force kratom users who manage acute or chronic pain to deadly opioids and will lead to increased opioid deaths in America.

Mr. President, we ask that you direct the FDA and the National Institute of Drug Abuse (NIDA) to research how kratom can best be used as both an alternative pain management therapy, and as a potential step-down from opioid addiction; and direct the Drug Enforcement Administration (DEA) to return the proposed scheduling recommendation for kratom to the FDA and NIDA for those additional studies -- and leave those Americans who use kratom for their personal health and well-being alone!

February 08, 2018

Mississippi Update

More good news for Mississippi... but the fight continues

"The AKA lobbyist in Mississippi has informed us that they were able to keep any anti-kratom amendments from being added today from the Senate floor. As the bills now cross over to the opposite chambers and signed to committee, our team will work with the committee members to keep the bills clean with no anti-kratom amendment."

#TeamAKA
#KeepKratomLegal
#IAmKratom

January 01, 2020

AKA Demands FDA Stop Its Disinformation Campaign Against Kratom

Nine Leading Scientists Challenge FDA Commissioner Gottlieb on War on Kratom

 

Washington, D.C. - February 8, 2018 - Nine leading scientists in substance addiction and safety wrote to White House Opioid Crisis Team Leader Kellyanne Conway and Acting DEA Administrator Robert W. Patterson requesting they disregard the FDA's latest disinformation campaign against kratom. The scientists warned that "four surveys indicate that kratom is presently serving as a lifeline away from strong, often dangerous opioids for many of the several million Americans who use kratom. A ban on kratom that would be imposed by CSA Scheduling would put them at risk of relapse to opioid use with the potential consequence of overdose death. Similar unintended consequences are to be expected in some who would be forced to use opioids to manage acute or chronic pain."

These scientists were united in their "collective judgment that placing kratom into Schedule I will potentially increase the number of deaths of Americans caused by opioids . . ."

 

The nine leading scientists directly challenged the claims by FDA Commissioner Scott Gottlieb that kratom is an opioid by pointing out the "available science is clear that kratom, although having effects on opioid receptors in the brain, is distinct from classical opioids (e.g. morphine, heroin, oxycodone, etc.) in its chemistry, biological effects, and origin (kratom is a tree in the coffee family, not the opium poppy family). Importantly, as commonly used in raw plant form, it does not appear to produce the highly addictive euphoria or lethal respiratory depressing effects of classical opioids."

 

David Herman, Chairman of the AKA, called upon FDA Commissioner Gottlieb to pull back the curtain on the "black box voodoo computer model" that was unveiled by the FDA to justify their continued 'War on Kratom,' this time claiming their computer model conclusively shows kratom is an opioid, and therefore had to be banned. 

 

"The FDA hoax on kratom is equivalent to the stunt pulled by Philip Davis, a graduate student at Cornell University in Ithaca, New York, who got a nonsensical computer-generated paper accepted for publication in a peer-reviewed journal, " Herman explained. "Davis and his colleagues used SCIgen, a program that generates nonsensical computer science papers. The FDA must have used the same code to generate their false report on kratom being as dangerous as opioids."

The nine respected scientists pointed out that "kratom provides a far more favorable safety profile for consumers compared to more dangerously addictive and potentially deadly classical opioid medications." They also pointed out that the FDA's solution - to file a new drug application for kratom - made no sense because "the average time and cost of new drug development is more than 10 years and 2.5 billion dollars."

 

The scientists also attacked the bad science the FDA used to claim deaths from kratom use, pointing out that "the fatalities that the FDA lists as having been associated with kratom include deaths with a wide variety of apparent causes in people suffering from various diseases and/or taking other substances that also likely contributed to their deaths. For example, it includes 9 fatalities in Sweden that resulted from an adulterated product that included the active substance of the prescription opioid tramadol (leading Swedish authorities to conclude that those deaths were caused by O-desmethyltramadol, not kratom). 

 

The assertion that a scheduling recommendation can be based on a claim of deaths 'associated with kratom' rather than deaths 'caused by kratom' is not, in our judgment, either scientifically valid nor the standard that was contemplated by the U.S. Congress for the scheduling of any substance under the CSA."

 

Finally, the nine scientists argued that American consumers should continue to have access to kratom. "We affirm our belief that the existing science on kratom does not justify its placement into Schedule I of the CSA, nor for kratom to be added to any local or state Controlled Substances list that would effectively remove it from consumer access."

 

The letter and supporting documents can be found at: https://www.americankratom.org/science-letter-on-kratom

 

ABOUT AKA

 

The American Kratom Association (AKA), a consumer-based non-profit organization, is here to set the record straight about kratom and give a voice to those who are suffering and protect their rights to possess and consume kratom. AKA represents tens of thousands of Americans, each of whom have a unique story to tell about the virtues of kratom and its positive effects on their lives. www.americankratom.org

 

MEDIA CONTACT 

 

Pete Candland, (703) 608-4649 -- pete.candland@americankratom.org 

 

Interviews with scientists signing the attached letter can be arranged by Mr. Candland.

#KeepKratomLegal

#IamKratom

#TeamAKA

February 06, 2018

AKA Postion Statement on FDA Press Release

This is an unprecedented abuse of science to create a new computer program that is clearly garbage in garbage out avoiding the rules of the Controlled Substances Act and making unproven claims that have been proven to be untrue. Example, Kratom per peer reviewed 8 Factor Analysis published in Psychopharmacology DOES NOT HAVE A RESPIRATORY DEPRESSION component as claimed by the FDA Our Scientists will review the statement but there are clear mistakes based on pre existing Confirmation Bias on the part of the FDA.

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse

February 05, 2018

LEGISLATIVE PROGRESS REPORT

Kratom Warriors and Guardians of Our Freedom:

 

The AKA recently received confirmation from our lobbyist in West Virginia that kratom has been removed from the schedule of controlled substances in HB 4336, and it's now being sent to the House Judiciary Committee for further action.

 

While this is welcome news for the kratom community, the battle in West Virginia is far from over. 

 

We caution every Kratom Warrior to remember that virtually every state legislature allows for individual members to offer amendments from the Floor of their respective legislative bodies. It's a serious mistake to claim victory too early because there are multiple opportunities to add kratom back to a bill or to a new one. This is true in most every state legislative body in the United States.

 

In West Virginia, HB 4336 now moves to the House Judiciary Committee where it is subject to amendments that could insert kratom back into the bill, then it would move to the House Floor for action where it could also be amended. Then, any House passed legislation goes to the West Virginia Senate to replicate the same process. There it will be reviewed by the Senate Health Committee, and then the Senate Judiciary Committee, and then heard on the Senate Floor.

 

Any amendments added to the bill could force another round of votes in the opposite chamber of the legislature, further extending the risk for amendments to add kratom. We have to remain vigilant throughout the term of the legislative session in each of the states where kratom bans have been proposed.

 

The AKA is extremely grateful for the support of the Kratom Warriors who have taken the time to reach out to legislators in West Virginia, and many other states across the country. Please stay alert for updates so that we can be prepared to react quickly to any moves to reinsert kratom back into legislation.

 

In that regard, we also ask the kratom community in Mississippi to stay on alert for amendments despite the encouraging results of the Committee actions that removed kratom from legislation in that state. It would simply be premature to declare victory and not stand watch until that legislative session is concluded.

 

The AKA continues to be active in Illinois, New York, Kansas, Florida, Tennessee, Mississippi, and West Virginia – and in other states where we hear that law enforcement and state Pharmacy Boards are active in advocating for kratom bans. 

 

It is due to your generosity that we are able to keep up the fight - thank you!  

 

#IAMKRATOM

#TeamAKA

#KeepKratomLegal

 

Sincerely,

Dave Herman

American Kratom Association 

 

P.S. Our first Guardian of our Freedom Legislative Phone Briefing is Sunday, February 11th. Please click the link below to pledge your support to #keepkratomlegal all year long and participate in monthly legislative calls and more. Thank you.

February 02, 2018

West Virginia, Mississippi and other State Updates

The AKA has just received confirmation from our lobbyist in West Virginia that kratom has been stripped from HB 4336, and it is now being sent to the House Judiciary Committee for further action.

While this is welcome news for the kratom community, the battle in West Virginia is far from over. We caution every Kratom Warrior that virtually every state legislature allows for individual members to offer amendments from the Floor of their respective legislative bodies. It is a serious mistake to claim victory to early because there are multiple opportunities to add kratom back to a bill or to a new one. This is true in most every state legislative body in the United States.

In West Virginia, HB 4336 now moves to the House Judiciary Committee where it is subject to amendments that could insert kratom back into the bill, then it would move to the House floor for action where could also be amended. Then, any House passed legislation goes to the West Virginia Senate to replicate the same process. There it will be reviewed by the Senate Health Committee, and then the Senate Judiciary Committee, and then heard on the Senate Floor.

Any amendments added to the bill could force another round of votes in the opposite chamber of the legislature, further extending the risk for amendments to add kratom. We have to remain vigilant throughout the term of the legislative session in each of the states where grading bands have been proposed.

The AKA is extremely grateful for the support of the Kratom Warriors who have taken the time to reach out to legislators in West Virginia, and the other states where kratom bans are proposed. Please stay alert for updates so that we can be prepared to react quickly to any sneak attacks to reinsert kratom back into legislation that we have been able to remove it from.

In that regard, we ask the kratom community in Mississippi to stay on alert for amendments despite the encouraging results of the Committee actions that removed kratom from legislation in that state. It would simply be premature to declare victory and not stand watch until that legislative session is concluded.

The AKA continues to be active in Illinois, New York, Kansas, Florida, Tennessee, Mississippi, and West Virginia – and in other states where we hear that law enforcement and state Pharmacy Boards are active in advocating for kratom bans. It is due to your generosity that we are able to keep up the fight.

January 24, 2018

Updates; WV, TN and Other Hot Spots

Kratom Warriors:

There is some confusion about what happened yesterday in West Virginia. As our Chief Lobbyist accurately predicted, the State Pharmacy Board and the State Police have convinced other legislators to re-file a Bill banning kratom.

While well-intentioned, the announcement that kratom had been removed from Senate Bill 2 was not the end of the story, and shows how important it is to have experienced and professional lobbyists working with us. As predicted by our Chief Lobbyist, a newly filed legislation - HB4263 - in the West Virginia House will ban kratom. We cannot be claiming victory until the battlefield has been cleared of all threats, and that will not happen in West Virginia until the bill filing deadline passes, and we have educated legislators on why the filed bills should remove kratom.

HB4263 has been assigned to the House Select Committee on Prevention and Treatment of Substance Abuse, and to the House Judiciary Committee.

For contact information on members of the West Virginia House Judiciary Committee

 

For contact information on members of the House Select Committee on Prevention and Treatment of Substance Abuse

 

The AKA strongly encourages its supporters to evaluate all the information before accepting reports of victories. Premature claims of victory leave us vulnerable to follow-on legislation, and can hurt the cause of keeping kratom if we rely on inaccurate and partial information.

 

The AKA has also learned that a new bill has been filed in Tennessee to ban kratom - HB1832 - so we will be updating you soon on a plan of action.

These states add to a growing list of hotspots which also include Mississippi, Kansas, and Illinois. We are tracking progress in each state and are working with local lobbying teams to assess next steps.

Stay alert, stay informed, and rely only on accurate information.

In other words, No Premature Victory Dance and Don't Poke the Bear!

 

#TeamAKA
#KeepKratomLegal
#IAmKratom

January 23, 2018

West Virginia

Directly from our lobbyist Mac Haddow.....

We just spoke with Jeff Johnson, who is Sen. Tom Takubo’s legislative aide in the West Virginia Senate. Takubo is the Chair of the Senate Health Committee. The Committee struck all of the listed substances, including kratom, because there were a few members who objected to the list of proposed scheduled substances. They dropped the new substances in order to save the entire bill. It is very likely that a freestanding bill will be filed because the State Board of Pharmacy and the State Police want all of those substances listed. The deadline for filing new bills in the Senate is February 19; and the deadline for filing new bills in the House is February 13. The last day of the West Virginia Legislature session is March 10. I think we should put out a Facebook post with this detail, and rally people on a grassroots campaign to the members of the Health and Judiciary Committees in both houses. The list of members is readily available on their website.

So this is an official call to action for West Virginia residents, get on the website, find those members. Start contacting them letting them know how you stand and why on kratom....

January 19, 2018

Guardian of Our Freedom Program

Join the AKA's Guardian of Our Freedom Program to Stop the Assault on Kratom

Become an AKA Guardian of Our Freedom

 

Kratom Warrior:

 

I just hung up from a call with our lobbying team who outlined the significant hotspots of anti-kratom activity both on the federal and state level.

 

I am not going to mince words, I am frustrated.

 

Anti-kratom activists, led by FDA Commissioner Scott Gottlieb, are committed to protecting the opioid manufacturers who are raking in billions of dollars every year by hooking honest Americans who are trying to manage chronic pain on highly addictive and potentially deadly opioids.

 

At the federal level, we continue to fight against the proposed scheduling recommendation for kratom made by the opioid manufacturer’s mouthpiece, FDA Commissioner Scott Gottlieb.

 

The Drug Enforcement Administration (DEA) is allegedly conducting their own "independent" 8-Factor Analysis that requires them to find that kratom has a high potential for abuse and that it is deadly before they can schedule kratom.

 

Neither are true, and each one of us knows it.

 

But the facts do not seem to matter much to these bureaucrats who are all in the pockets of the opioid manufacturers.

 

Last week, 25 courageous Members of Congress stood up for kratom by putting their names on a letter to the DEA defending our freedoms, and now I hope you will stand with them against this outrageous overreach by the FDA and the DEA.

 

At the state level, the opioid manufacturers have deployed their lobbying teams to persuade state legislators to add kratom to the controlled substances list of individual states, effectively banning consumers from their freedom to make their own decisions on pain management and their health and well-being.

 

This is going to be a long, drawn-out fight, and I need your help today and throughout the year. This is not a one-time battle, it's an all-out WAR.

 

The Board of Directors has authorized the creation of the AKA Guardian of Our Freedom program to ensure we have the funds to fight all year long.

 

I am asking you to make a commitment of $25 each month for the next 12 months to make certain we have the lobbying and public relations teams in place to fight for our freedoms.

 

It is a way to honor the 25 Members of Congress who stood with us today.

 

If you become an AKA Guardian of Our Freedom program, here is my commitment to you:

 

  • On the first Sunday of the month, each and every month, at 8:30 PM EST, you will be invited to a AKA Guardian of Our Freedom online briefing from our lobbying team.

 

  • You will receive an automatic email alert every time a significant action is taken on kratom at the federal or state levels.

 

  • Your name will be automatically added to every official AKA Guardian of Our Freedom communication we send to the Congress, the Executive Branch and to state legislatures making the case for protecting our freedom to use kratom.  If you do not want your name included, you will have the ability to opt out.  You can opt out now by sending an email to support@americankratom.org

 

  • You can opt out of your monthly commitment at any time that you feel your investment is not yielding results.

 

I am asking for this help because, the truth is, our funds are running out. We have a plan for an aggressive counterpunch to the FDA Commissioner Scott Gottlieb to show that the science on kratom proves that it is neither highly addictive nor dangerously unsafe for use.

 

But we cannot do this without your help, your commitment, and this AKA Guardian of Our Freedom program will allow us to plan for the funds needed for sustained campaign.

 

There is no doubt in my mind that the FDA and the opioid manufacturers are twisting the arms of the DEA to rubberstamp their scheduling proposal for kratom.

 

I am equally confident that we can win this battle, but only if we make the sacrifices necessary to protect our freedoms.

 

Will you join me in fighting on your behalf?

Please click on the link below and sign up today to be an AKA Guardian of Our Freedom Warrior for kratom.

 

Thank you for all of your past support and accept my gratitude for your willingness to help now.

 

Sincerely,

Dave Herman, Chairman

American Kratom Association

Become an AKA Guardian of Our Freedom

#KeepKratomLegal

#IamKratom

#TeamAKA

January 18, 2018

Brief Update on the States facing legislation:

•Illinois (HB 4106): AKA has hired an amazing lobbyist with past legislative experience as well.

 

•New York (A 8787, SB 6924 & A 231): AKA has had our federal lobbyist working there and we are continuing to monitor very closely.

 

•West Virginia (SB 2, HB 4003 & SB 273);

 

•Mississippi (HB 974, SB 2475);

 

AKA is currently interviewing lobbyists for WV, MS & potentially FL again this year.

 

•Kansas (SB 282): AKA is monitoring closely (there is no companion bill yet).

 

~Thank you to all who donate to support the efforts & resources needed for AKA to keep fighting for everyone’s right to choose kratom for their health & well being.


As you can see, it’s a very active legislative season already.

 

#KeepKratomLegal #IAmKratom #TeamAKA

January 14, 2018

THE AMERICAN KRATOM ASSOCIATION WORKS WITH CONGRESSMEN POCAN (D-WI) AND CONGRESSMAN LOBIONDO (R-NJ) TO GAIN BI-PARTISAN SUPPORT FOR LETTER TO THE DEA

“This letter sends a loud and clear message to the DEA that they need to look at the actual science of kratom, not the misinformation being pushed by the FDA”


WASHINGTON, D.C. -- January 14, 2017 – The American Kratom Association (AKA) strongly agrees with the bi-partisan Congressional letter signed by 25 Members of the House of Representatives from across the United States urging the DEA to adhere to the requirements of the Controlled Substances Act in their review of kratom.  

The statute requires that scheduling only be done when there is conclusive scientific and legally defensible proof that the substance being reviewed has (1) a high potential for abuse, and (2) that it is unsafe for consumer use.  
 
In a statement, the Chairman of the AKA, Dave Herman, said: “The American Kratom Association is extremely grateful to Congressmen Pocan and LoBiondo, and their staffs, for their extraordinary efforts in obtaining broad, bi-partisan support for this letter.  We know that the misinformation blitz on Capitol Hill from the FDA has been intense, and we appreciate the courage that all 25 Representatives demonstrated by co-signing this letter.”

“The FDA has published completely false information on alleged deaths and adverse event reports from kratom use that completely undermines the intent of the CSA,” Herman stated.  “The FDA is trying to do an end-run around the Congressional intent to ban kratom as a part of a broader regulatory campaign to remove any product consumers use for pain management that the FDA has not reviewed under the onerous and expensive new drug application process.”

The FDA has recently announced aggressive enforcement actions against a broad array of alternative pain management products in homeopathy, medical foods, and dietary supplements that are currently safely used by consumers to manage pain rather than use highly addictive and often deadly opioid prescription drugs.

“It’s unfathomable that the FDA would choose to attack consumers by banning pain management alternatives safely used by consumers to drive them to opioids that have proven to be a public health crisis – killing more than 90 Americans a day,” Herman continued.  “I am hopeful that the President will step in to support his own Commission’s recommendation to expand the availability of non-opioid pain management options for people suffering from pain.” 

Dave Herman continued, “We are extremely appreciative of all the groups who supported and promoted this letter.  The science is on our side.  Let me be clear, scientific evidence demonstrates that kratom does not kill people.  Kratom is not an opioid.  Kratom does not have the same effects as an opioid, and kratom is not an analogue of an opioid.  This letter sends a loud and clear message to the DEA that they need to look at the actual science of kratom, not the misinformation being pushed by the FDA.”

“The FDA has resorted to using trumped up claims of safety when the science is clear they are wrong, and they are repeating the same game plan of trying to demonize any product that is not a prescription drug just like they did in the early 1990s when Congress had to slap the FDA down with the passage of the Dietary Supplement Health and Education Act of 1994 (DSHEA),” Herman concluded.  “Clearly the Congress will have to step in and restrain the FDA once again as they try to expand their demonization of non-opioid pain management products.”

The AKA would like to thank the following Representatives in Congress who signed the letter:


Rep. Pocan (D-WI)
Rep. LoBiondo (R-NJ)
Rep. Brat (R-VA)
Rep. Rohrabacher (R-CA)
Rep. Polis (D-CO)
Rep. DeFazio (D-OR)
Rep. Gosar (R-AZ)
Rep. Blumenauer (D-OR)
Rep. Soto (D-FL)
Rep. Napolitano (D-CA)
Rep. Lee (D-CA)
Rep. Budd (R-NC)
Rep. Khanna (D-CA)
Rep. Gabbard (D-HI)
Rep. Jayapal (D-WA)
Rep. Rush (D-IL)
Rep. Bergman (R-MI)
Rep. Johnson (D-GA)
Rep. Cohen (D-TN)
Rep. Moore (D-WI)
Rep. Lofgren (D-CA)
Rep. Jones (R-NC)
Rep. Krishnamoorthi (D-IL)
Rep. Hanabusa (D-HI)
Rep. Norton (D-DC)
 

ABOUT AKA
 
The American Kratom Association (AKA), a consumer-based non-profit organization, is here to set the record straight about kratom and give a voice to those who are suffering and protect their rights to possess and consume kratom. AKA represents tens of thousands of Americans, each of whom have a unique story to tell about the virtues of kratom and its positive effects on their lives. www.americankratom.org


#IAMKRATOM
#WeAreKratom
#keepkratomlegal
#TeamAKA

MEDIA CONTACTS:  Pete Candland, Executive Director of the AKA, (703) 608-4649,  pete.candland@americankratom.org 

LEARN MORE

January 11, 2018

Let's Flood the Phone Lines on Capitol Hill!

Kratom Warriors:


First let me say "thank you" to everyone who has called their member of Congress this week and asked them to support the Pocan/LoBiondo "Dear Colleague" letter.  Your actions have helped us build an impressive list of supporters.  

YOU CAN VIEW THE LETTER HERE

But we need one more push!

It's time to flood the phone lines on Capitol Hill!

Our team in D.C. has informed us that the FDA has engaged in a full blitz to demonize kratom on the Hill.  They continue to blanket Congressional offices with the same misinformation they fed to the public - and they are telling lie after lie that kratom kills people.  

As we've said for months - it's clear that the FDA wants to ban kratom.  The FDA wants to strip us of our freedom to make our own choices about our health and well-being.

If you haven't done so this week, please pick up the phone RIGHT NOW and call your member of Congress and ask them to sign onto the Pocan/LoBiondo letter.

If you do not know the phone number for your member of Congress, you can just call the main US Capitol switchboard at 202-224-3121 and ask to be transferred to your Representative's office.

When you talk to the staffer who answers the phone, tell them how important it is to you that your Representative in Congress sign the Pocan/LoBiondo kratom letter to the DEA.

Please, pick up the phone and make the call immediately. We must finish strong with this letter and send a clear message that kratom needs to remain legal.

Thank you!

Dave Herman
Chairman
American Kratom Association

#IAMKRATOM
#TeamAKA
#KeepKratomLegal

DONATE

January 04, 2018

Kratom Legislative Briefing Webinar

Speakers are Dave Herman, AKA Chairman, Dr. Jack Henningfield and Mac Haddow, AKA Legislative Director
 

January 05, 2018

One More Push: Call Your Representative and ask them to Support the Pocan/LoBiondo Letter

Kratom Warriors:

I hope you had a wonderful holiday season and let me start by saying, Happy New Year!

Let me get straight to the point.  

Our team has been working with Congressmen Pocan and LoBiondo for months on a letter to the DEA telling them to follow the science about kratom, not just blindly following the directive from the FDA to ban kratom.

YOU CAN VIEW THE LETTER HERE

And the FDA has responded with a strong attack on kratom on Capitol Hill.  They are blanketing Congressional offices with the same misinformation they fed to the public - and they are telling lie after lie that kratom kills people.  

The FDA has gone all in with a push to get the DEA to schedule kratom as a Schedule I controlled substance.  

The FDA wants to ban kratom.  The FDA wants to strip us of our freedom to make our own choices about our health and well-being.

The FDA wants to force all alternative pain management therapies, including kratom, into the new drug application process to they can regulate it.

It's about making possessing kratom a crime, and they want to prosecute every American who uses kratom.

We need your help getting other Congressmen to sign onto the letter.  The more co-signers, the bigger impact it will make.  

The DEA is preparing to publish its Notice to Schedule Kratom that will make every kratom user a criminal.  Time is running out for us to act.

There are some in the kratom community who don’t think the DEA will try to schedule kratom.  If you think that, you are wrong!

I am asking you to please pick up the phone TODAY and call your member of Congress and ask them to sign onto the Pocan/LoBiondo letter.

The DEA has to know that Congress is watching what they are doing, and they had better base their decision on the science. 

That is where we win.

This is our chance to stop the Notice to Schedule Kratom in its tracks, but it will not happen without your help today.

If you do not know the phone number for your member of Congress, you can just call the main US Capitol switchboard at 202-224-3121 and ask to be transferred to your Representative's office.

When you talk to the staffer who answers the phone, tell them how important it is to you that your Representative in Congress sign the Pocan/LoBiondo kratom letter to the DEA.

Please, pick up the phone and make the call immediately. Today is a critical day in the fight to protect kratom.

Thank you for your support and I know that with all of us working together, we can keep kratom legal.  

Dave Herman
Chairman
American Kratom Association

#IAMKRATOM
#teamAKA
#KeepKratomLegal

DONATE

December 21, 2017

Pocan/LoBiondo Dear Colleague Letter Update

We received word today from Congressman Pocan that while we have over 20 signers, he believes that once the legislative crush is over, we will receive more.  He wants to give his fellow Congress members every chance to sign on and therefore made the decision to hold the letter open until after the first week of January.  We would like to take this opportunity to once again thank Congressman Pocan and LoBiondo for their belief in and support of our worthy cause.

December 19, 2017

Ask Your Representative to Support the Pocan/LoBiondo Letter To Make Sure the DEA Reviews the Science on Kratom

Kratom Warriors:

I know that everyone is busy preparing for the holidays, but I am writing because we need your help TODAY.

The DEA is preparing to publish its Notice to Schedule Kratom that will make every kratom user a criminal.

Make no mistake, that threat is real.

I am asking you to pick up the phone and call your member of Congress and ask them to sign onto the Pocan/LoBiondo letter; telling the DEA to follow the science, not the directive from the FDA to ban kratom.

YOU CAN VIEW THE LETTER HERE

Last year, more than 51 members of the House of Representatives cosigned a letter to the DEA.  That letter made a huge difference.  

We now have a chance to stop the Notice to Schedule Kratom in its tracks, but it will not happen without your help today.

If you do not know the phone number for your member of Congress, you can just call the main US Capitol switchboard at 202-224-3121 and ask to be transferred to your Representative's office.

When you talk to the staffer who answers the phone, tell them how important it is to you that your Representative in Congress sign the Pocan/LoBiondo kratom letter to the DEA.

We fought and won this battle last year, but we cannot drop the ball now that the FDA has renewed its war on kratom.

Please, pick up the phone and make the call immediately. Today is a critical day in the fight to protect kratom.

The DEA needs to know that we will fight to protect our freedom to make our own personal choices about our health and well-being, and we do not need big government telling us what to do or criminalizing the responsible use of a safe botanical.

Thank you for your support to keep kratom legal.

Dave Herman

#IAMKRATOM
#TeamAKA
#KeepKratomLegal

DONATE

December 16, 2017

AKA RESPONSE TO FALSE CHARGES

Dear Kratom Nation:

 

The war on kratom continues in Washington DC, and there is no doubt in my mind that the career FDA staff will do anything they can to expand the regulatory powers over botanicals and dietary supplements, including a deliberately orchestrated misinformation campaign that is fueling the FDA's recommendation to the DEA to schedule kratom as a Schedule I dangerously addictive and deadly substance.

 

The American Kratom Association (AKA) is committed to do all we can to protect the freedom of consumers to have access to kratom, and to make their own personal decisions on the responsible use of botanicals and dietary supplements in managing their health and well-being.

 

I am writing today to address a series of comments that had been made in various social media platforms that have no apparent purpose other than to be self-destructive and undermine the efforts that are being made to keep kratom legal. Under normal circumstances, it might be excusable for competing factions within a coalition of like-minded people to take an occasional shot of one another.

 

But these are not normal circumstances, and every second that we are diverted away from the common goal that we all share to preserve and protect the legality of kratom is a lost opportunity, and increases the risk that the FDA and the DEA will be successful in completely banning kratom from the marketplace.

 

The FDA published a notice recently that another New Dietary Ingredient (NDI) application was rejected for a kratom product for purported failures to meet required regulatory standards demonstrating the safety of these products. There are some factions in the kratom community who decided to use this event as a platform to take pot-shots against the AKA to advance their own transparently self-serving agendas.

 

I am happy to provide the following responses to the issues that have been raised by individuals affiliated with entities that are in direct competition with the AKA:

 

FALSE CLAIM #1:  The AKA is funded and controlled by two vendors of kratom products, Sebastian Guthery and Steve Curtis. I have reviewed the financial records for AKA from August 1, 2016 to the current date, and I can tell you that neither these individuals has made any donations to AKA.

 

The AKA supports a robust kratom industry, including product manufacturers who adhere to the AKA Statement of Principles regarding the manufacturing and marketing of kratom products for responsible use by the public. We would welcome financial contributions from any source that shares our commitment to these Principles, but we do not let any contributor "control" or exercise any improper influence over the decisions of the governing authority of the AKA, which is its Board of Directors.  If Mr. Curtis or Mr. Guthery were to offer a donation in the future it would be treated as any other donor to AKA.

 

FALSE CLAIM #2:  The AKA is somehow compromised because it has retained the same law firm as the company who most recently had its NDI rejected by the FDA.

 

Hogan Lovells is a highly respected international law firm with more than 2,800 attorneys. Hogan specifically has a specialty in FDA regulatory policy, and an emphasis in the dietary supplement area.

 

Hogan was instrumental in developing the legal arguments that were used effectively in our battle against the emergency scheduling notice to ban kratom in 2016. Hogan also has a rigorous internal conflict of interest policy that protects each client and their interests from being compromised by any real or perceived conflicts of interest. The AKA is confident that we have received the best advice. Most importantly, the AKA has only paid invoices related to the efforts by Hogan to support the AKA initiative to keep kratom legal. Any claim that AKA has subsidized legal work for any kratom manufacturer is completely false.

 

FALSE CLAIM #3:   The AKA’s unwillingness to "open our books" to show the names and amounts of contributors demonstrates a lack of transparency and somehow validates the false claims being made by those detractors who are promoting the self-serving agenda of competing organizations. In fact, the AKA follows the same practice of most nonprofit organizations who maintain the confidentiality of individual donors and the amounts contributed because of the costs involved in developing a solid base of donors to support ongoing AKA initiatives.

 

The issue is whether any single donor, or a small group of donors, controls or influences the policy decisions of the AKA. The AKA Board of Directors meets regularly and spends many hours discussing and strategizing about the best course of action for advocacy, and our decisions are a consensus of the majority of those Board members following those discussions. No one individual, or small group of individuals, whether donors or not, exercise any undue or improper influence on any decision made by the AKA Board of Directors.

 

SUMMARY:  The AKA does the best it can with limited financial resources to fight the battles at the federal, state and local levels to keep kratom legal. We believe that our success speaks for itself. Through the generous donations of individual contributors, AKA deployed significant resources in Florida, West Virginia, Utah, New York, Oregon, and Maine in 2016. While there were some groups who provided additional support in some of those states, no other kratom advocacy group matches the effort organized and directed by AKA.

 

The AKA has also been able to use these donations to fund critically important research that documents the safety of kratom in the marketplace. The 8-Factor Analysis authored by Jack Henningfield, PhD, is the seminal document that directly contradicts the addiction safety claims now being made by the FDA. It is ironic that some of the detractors from other competing entities liberally use this document without attribution to the AKA, including using it for fundraising purposes in a blatantly unethical use of intellectual property that was funded completely by AKA.

 

In addition, the AKA has funded the recently concluded survey on kratom use by consumers in dealing with pain management issues that clearly demonstrates that kratom is a valuable alternative to opioids that are dangerously addictive and deadly. This research conducted by Dr. Henningfield will be an important document supporting our advocacy for keeping kratom legal and accessible to consumers.

 

The AKA is presently gearing up for what promises to be a robust state legislative season where our anti-kratom detractors will be promoting kratom bans in the states. The AKA is the only kratom advocacy organization that is engaged with legislators across the country in discussing these issues at their policy meetings, including the recently concluded National Conference of State Legislatures (NCSL) Capitol Forum that was held in San Diego, California last week.

 

It is difficult to understand why these recent criticisms have arisen unless you understand the connection between the Statement of Principles published by the AKA wherein we support self-regulation in the kratom industry that restrict children from purchasing kratom products; appropriate child resistance packaging; standards for product purity as exist for most food products; restrictions on adulterated kratom products and adherence to good manufacturing standards; and limiting any claims and labeling for kratom products to those allowed by the Dietary Supplement Health and Education Act of 1994 (DSHEA).

 

The AKA believes that keeping kratom legal and accessible to consumers requires responsible manufacturing and marketing to protect consumers and minimize any potential irresponsible uses of kratom products. I have become aware of several new products that are being introduced to the kratom marketplace that are clearly inconsistent with the AKA Statement of Principles, including those formulated in Chewable Kratom-Cherry flavor and  Buzz Gum that appear to be targeted, at least in part, to use by children.

 

In that context, the newly-raised criticisms against AKA are more understandable and they shine a bright light on those detractors who obviously have no interest in adhering to any reasonable standards that will ensure the continued responsible use of kratom by consumers.

 

I restate the unequivocal commitment of the AKA Board of Directors to continue to develop responsible advocacy messages to convince policymakers the kratom should remain legal and accessible to consumers. We will not be distracted from that goal by the emerging orchestrated campaign because the AKA Statement of Principles represents a threat to some manufacturer or marketer of an irresponsibly formulated kratom product. We make no apology for doing so.

The Board of the American Kratom Association

#KeepKratomLegal

#TeamAKA

#WeAreKratom

December 15, 2017

American Kratom Association 2017 Year In Review Year End Campaign for Kratom

Donate

 

Kratom Warriors,

 

When we look back on 2017, this year will be marked by the continual assault by the FDA/DEA to ban kratom . 

 

We will remember the ongoing coordinated campaigns by the anti-kratom groups to intentionally spread misinformation about kratom, the outrageous claims about “kratom overdoses” and the constant state of worry about an eminent banning of a botanical that has helped so many people improve their lives.